Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · Real-Time Price · USD
12.40
+0.09 (0.73%)
Oct 29, 2024, 4:00 PM EDT - Market closed

Stoke Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2017
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2017
Revenue
15.168.7812.41---
Upgrade
Revenue Growth (YoY)
71.38%-29.22%----
Upgrade
Gross Profit
15.168.7812.41---
Upgrade
Selling, General & Admin
44.1441.3238.9231.920.8511.91
Upgrade
Research & Development
85.5582.2377.8454.1732.223.76
Upgrade
Operating Expenses
129.69123.55116.7686.0753.0435.68
Upgrade
Operating Income
-114.53-114.77-104.36-86.07-53.04-35.68
Upgrade
Interest & Investment Income
11.369.913.120.120.73.35
Upgrade
Other Non Operating Income (Expenses)
-0.390.170.170.140.10
Upgrade
Pretax Income
-103.57-104.7-101.07-85.81-52.24-32.33
Upgrade
Net Income
-103.57-104.7-101.07-85.81-52.24-32.33
Upgrade
Net Income to Common
-103.57-104.7-101.07-85.81-52.24-32.33
Upgrade
Shares Outstanding (Basic)
484439373318
Upgrade
Shares Outstanding (Diluted)
484439373318
Upgrade
Shares Change (YoY)
15.83%13.10%5.87%9.71%86.34%2433.56%
Upgrade
EPS (Basic)
-2.16-2.38-2.60-2.34-1.56-1.80
Upgrade
EPS (Diluted)
-2.16-2.38-2.60-2.34-1.56-1.80
Upgrade
Free Cash Flow
-80.62-82.68-35.83-68.11-43.27-32.69
Upgrade
Free Cash Flow Per Share
-1.68-1.88-0.92-1.85-1.29-1.82
Upgrade
Gross Margin
100.00%100.00%100.00%---
Upgrade
Operating Margin
-755.65%-1307.21%-841.24%---
Upgrade
Profit Margin
-683.31%-1192.47%-814.73%---
Upgrade
Free Cash Flow Margin
-531.93%-941.72%-288.82%---
Upgrade
EBITDA
-112.16-112.3-102.81-85.09-52.16-35.23
Upgrade
D&A For EBITDA
2.372.471.550.970.890.45
Upgrade
EBIT
-114.53-114.77-104.36-86.07-53.04-35.68
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.